Can-Fite BioPharma Ltd.
CANF | AMEX
$2.22
-$0.02 (-0.89%)
At close: Sep 21, 2026, 4:00 PM ET
$2.26
+$0.04 (+1.74%)
Pre-market:
Sep 22, 2026, 6:16 AM ET
Fiscal Quarter Period Ending | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 | Q4 2020 Dec 30, 2020 | Q3 2020 Sep 29, 2020 | Q2 2020 Jun 29, 2020 | Q1 2020 Mar 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 101K | 101K | 179K | 179K | 158K | 158K | 155K | 196K | 196K | 196K | 197K | 204K | 204K | 205K | 204K | 251K | 250K | 148K | 150K | 211K | 204K | 198K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 101K | 101K | 179K | 179K | 158K | 158K | 155K | 196K | 196K | 196K | 197K | 204K | 204K | 205K | 204K | 251K | 250K | 148K | 150K | 211K | 204K | 198K |
Operating Income | -2.45M | -2.45M | -2.02M | -2.02M | -2.05M | -2.05M | -1.83M | -1.87M | -1.78M | -2.71M | -3.08M | -2.57M | -2.07M | -2.5M | -4.03M | -3.51M | -3.13M | -2.17M | -3.55M | -2.48M | -3.83M | -4.28M |
Interest Income | 11K | 11K | 77K | 77K | 68.5K | 68.5K | 127K | 106K | 111K | 162K | 363K | 44K | n/a | n/a | n/a | 110K | n/a | 293K | 21K | n/a | n/a | n/a |
Pretax Income | -2.44M | -2.44M | -1.96M | -1.96M | -1.98M | -1.98M | -1.65M | -1.76M | -1.67M | -2.55M | -3.02M | -2.53M | -2.19M | -2.43M | -4.12M | -3.4M | -3.22M | -1.88M | -3.63M | -2.58M | -3.89M | -4.34M |
Net Income | -2.44M | -2.44M | -1.96M | -1.96M | -1.98M | -1.98M | -1.65M | -1.76M | -1.67M | -2.39M | -2.96M | -2.44M | -2.43M | -2.56M | -4.12M | -3.4M | -3.22M | -1.88M | -3.63M | -2.58M | -3.89M | -4.34M |
Selling & General & Admin | 1.03M | 1.03M | 761K | 761K | 762.5K | 762.5K | 722K | 762K | 624K | 847K | 826K | 741K | 822K | 754K | 1.13M | 822K | 876K | 1.02M | 807K | 689K | 752K | 703K |
Research & Development | 1.52M | 1.52M | 1.44M | 1.44M | 1.44M | 1.44M | 1.27M | 1.3M | 1.36M | 2.06M | 2.45M | 2.04M | 1.45M | 1.82M | 3.1M | 2.94M | 2.51M | 1.3M | 2.9M | 2M | 3.28M | 3.77M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.55M | 2.55M | 2.2M | 2.2M | 2.21M | 2.21M | 1.99M | 2.06M | 1.98M | 2.91M | 3.28M | 2.78M | 2.27M | 2.58M | 4.23M | 3.76M | 3.38M | 2.32M | 3.7M | 2.69M | 4.04M | 4.47M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 14K | 3K | n/a | n/a | 16K | n/a | 121K | 64K | 315K | n/a | 86K | n/a | 139K | 96K | 62K | 66K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.55M | 2.55M | 2.2M | 2.2M | 2.21M | 2.21M | 1.99M | 2.06M | 1.98M | 2.91M | 3.28M | 2.78M | 2.27M | 2.58M | 4.23M | 3.76M | 3.38M | 2.32M | 3.7M | 2.69M | 4.04M | 4.47M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.5K | -4K | -162K | -64K | -88K | 242K | 128K | n/a | -3K | -4K | -3K | n/a | -3.5K | -3K | -3.5K |
Shares Outstanding (Basic) | 11.38M | 11.38M | 8.44M | 8.44M | 6.07M | 6.07M | 4.95M | 4.08M | 4.09M | 3.93M | 2.72M | 2.72M | 2.72M | 2.72M | 1.36M | 1.83M | 1.72M | 1.61M | 1.55M | 1.53M | 1.03M | 576.51K |
Shares Outstanding (Diluted) | 11.37M | 11.37M | 8.44M | 8.44M | 6.07M | 6.07M | 4.95M | 4.08M | 4.08M | 3.93M | 2.72M | 2.72M | 2.72M | 2.72M | 2.22M | 1.83M | 1.72M | 1.61M | 1.55M | 1.53M | 1.03M | 671.45K |
EPS (Basic) | -0.21 | -0.21 | -0.24 | -0.24 | -0.33 | -0.33 | -0.33 | -0.42 | -0.42 | -0.66 | -1.11 | -0.93 | -0.81 | -0.90 | -3.03 | -1.86 | -1.86 | -1.17 | -2.34 | -1.68 | -3.78 | -7.53 |
EPS (Diluted) | -0.21 | -0.21 | -0.24 | -0.24 | -0.33 | -0.33 | -0.33 | -0.42 | -0.42 | -0.66 | -1.11 | -0.93 | -0.81 | -0.90 | -3.03 | -1.86 | -1.86 | -1.17 | -2.34 | -1.68 | -3.78 | -7.53 |
EBITDA | -2.44M | -2.44M | -2.02M | -2.02M | -2.05M | -2.05M | -1.83M | -1.86M | -1.78M | -2.71M | -3.08M | -2.57M | -2.07M | -2.37M | -4.02M | -3.51M | -3.13M | -2.17M | -3.55M | -2.48M | -3.83M | -4.27M |
EBIT | -2.45M | -2.45M | -2.02M | -2.02M | -2.05M | -2.05M | -1.83M | -1.87M | -1.78M | -2.71M | -3.08M | -2.57M | -2.07M | -2.37M | -4.03M | -3.51M | -3.13M | -2.17M | -3.49M | -2.48M | -3.83M | -4.28M |
Depreciation & Amortization | 11.5K | 11.5K | 3K | 3K | 500 | 500 | 3.75K | 3.5K | 4K | 3.5K | 3.5K | 3.5K | 3K | 3.5K | 3.5K | 3K | 4K | 3K | 3K | 3.5K | 3K | 3.5K |
Add to Watchlist
Select watchlists to add or remove CANF